ORBIMED ADVISORS LLC

AUM: $18.28 B
13-F Portfolio Value: $5.01 B
Last 13-F Filed: Q4 2023
Concentration in top 10: 36.49%
Filter by:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
ELVELEVANCE HEALTH INC1.27%141,500$66,725,740141,500New$471.5613F
QTTBQ32 Bio Inc.0.74%2,252,987$37,512,2342,252,987New13D
AVBPArriVent Biopharma, Inc.0.52%1,513,664$27,245,9521,513,664NewForm 4
ALNYALNYLAM PHARMACEUTICALS INC0.29%79,400$15,197,95479,400New$191.4113F
PFEPFIZER INC (Call)0.27%500,000$14,395,000500,000New$28.7913F
KRYSKRYSTAL BIOTECH INC0.24%103,700$12,865,022103,700New$124.0613F
FOLDAMICUS THERAPEUTICS INC0.22%806,000$11,437,140806,000New$14.1913F
DXCMDEXCOM INC0.17%73,200$9,083,38873,200New$124.0913F
ILMNILLUMINA INC0.08%30,300$4,218,97230,300New$139.2413F
AMAMAMBRX BIOPHARMA INC0.08%296,000$4,215,040296,000New$14.2413F
RCUSARCUS BIOSCIENCES INC0.04%117,000$2,234,700117,000New$19.113F
CLDXCELLDEX THERAPEUTICS INC NEW0.04%58,800$2,332,00858,800New$39.6613F
FATEFATE THERAPEUTICS INC0.04%528,080$1,975,019528,080New$3.7413F
TXG10X GENOMICS INC0.04%39,800$2,227,20839,800New$55.9613F
AGIOAGIOS PHARMACEUTICALS INC0.02%45,000$1,002,15045,000New$22.2713F
GERNGERON CORP0.02%485,000$1,023,350485,000New$2.1113F
VIRVIR BIOTECHNOLOGY INC0.02%101,000$1,016,060101,000New$10.0613F